Previous 10 | Next 10 |
YYY has lost about 18% in share price since inception. It has also lost more than 30% in monthly distribution. This is before accounting for inflation. It may get worse in a rising rate environment. For further details see: YYY: Shrinking Value And Income
PCEF facts and performance. Comparing PCEF with my CEF benchmark. Scanning the PCEF portfolio. A different way to invest in CEFs. For further details see: Why I Won't Touch PCEF With A 10-Foot Pole
Tekla Life Sciences (HQL) declares $0.43/share dividend.Payable March 31; for shareholders of record March 26; ex-div Feb. 25.See HQL Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Tekla Life Sciences declares $0.43 dividend
Risk assets continued their historic run last week with EM equities and commodities leading the way. Bonds sold off as the 10-year Treasury note yield broke above 1.20% for the first time since the lows last spring. The 10-year TIPS yield closed the week at 1.02%, near the all-tim...
After a dramatic year of volatility, the U.S. stock market ended 2020 at record highs. Can this momentum continue this year? ESG investments clearly outperformed in 2020. 2021 should be a year of much better cash flow for companies. For further details see: A Stock Picke...
2020 was a busy year for global healthcare with unprecedented efforts to develop vaccines, treatments, and diagnostics for COVID-19. Deal flow in the sector continued to gain momentum in 2020, with M&A transactions and product licensing deals totalling five-year highs as large-cap...
HQH offers investors a managed quarterly distribution based on 2% of the NAV. The fund's discount has been tightening lately, but is still attractive for long-term investors. The healthcare exposure provides for a mixture of recession-resistant investments that worked especially w...
HQL has outperformed other healthcare-oriented CEFs over the past year. It's selling at a -7.27% discount to NAV. It yields 7.94%, and is a good watchlist candidate. For further details see: Tekla Life Sciences Investors: 8% Yield, 7% Discount
Recent positive developments in COVID-19 vaccines have spurred a wave of market exuberance, lifting share prices of biotech companies at the forefront of the vaccine race. COVID-19 and the urgency to find a cure have opened up opportunities, making the biotech sector a prospective spa...
Tekla Life Sciences (HQL) declares $0.02/share special dividend.Payable Jan. 6; for shareholders of record Dec. 31; ex-div Dec. 30.See HQL Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Tekla Life Sciences declares $0.02 special dividend
News, Short Squeeze, Breakout and More Instantly...
TeklaLife Sciences Investors Company Name:
HQL Stock Symbol:
NYSE Market:
TeklaLife Sciences Investors Website:
2024-08-01 06:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-25 05:00:37 ET Few people pay much attention to the management team of a closed-end fund (CEF). But it’s becoming a much more critical factor driving CEF upside (and downside!), as well as these funds’ 8%+ dividend payouts. I was reminded of this recently by a ...
PHILADELPHIA, PA / ACCESSWIRE / June 26, 2024 / abrdn Life Sciences Investors ("HQL") announced today the results of the Annual Meeting of Shareholders (the "Meeting"), held on June 25, 2024. As of the record date, April 1, 2024, HQL had outstanding 27,350,517 shares of common stock. 87.84% o...